Azitra (AZTR) Operating Margin (2022 - 2024)
Azitra's (AZTR) quarterly Operating Margin came in at 35470.4% in Q2 2024, down 3464041.0% YoY from N/an in Q3 2023, and down 1192.19% on a QoQ basis from 2744.97% in Q4 2023.
Azitra (AZTR) Operating Margin (2022 - 2024) Analysis & Trends
Azitra (AZTR) has 3 years of Operating Margin data on file, last reported at 35470.4% in Q2 2024.
- Quarterly Operating Margin fell 3464041.0% year-over-year to 35470.4% in Q2 2024, while the trailing twelve-month figure through Jun 2025 was 151132.71% (down 14866186.0% YoY) and the FY2024 annual result came in at 146468.53%, down 14538245.0% from the prior year.
- Operating Margin slipped to 35470.4% in Q2 2024, from 2744.97% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 641.69% in Q3 2023 to a low of 35470.4% in Q2 2024.
- A 3-year average of 7156.69% and a median of 2600.95% in 2022 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2023 — Operating Margin soared 610123 bps — and 2024, when it plunged 3464041 bps.
- Tracing AZTR's Operating Margin over 3 years: stood at 8846.2% in 2022, then soared by 69 bps to 2744.97% in 2023, then slumped by 1192 bps to 35470.4% in 2024.
- The last three Operating Margin figures came in at 35470.4% (Q2 2024), 2744.97% (Q4 2023), and 641.69% (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Azitra | 2.44 Mn | 2.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -35,470.40% |
| Dec 31, 2023 | -2,744.97% |
| Sep 30, 2023 | -641.69% |
| Jun 30, 2023 | -829.99% |
| Mar 31, 2023 | -1,375.77% |
| Dec 31, 2022 | -8,846.20% |
| Sep 30, 2022 | -4,887.53% |
| Jun 30, 2022 | -2,456.93% |